Englisch C, Moik F, Thaler J, Koder S, Mackman N, Preusser M, Pabinger I, Ay C. Tissue factor pathway inhibitor is associated with risk of venous thromboembolism and all-cause mortality in patients with cancer. haematol [Internet]. 2024Mar.31 [cited 2024May21];109(4):1128-36. Available from: https://haematologica.org/article/view/haematol.2023.283581